HAS2 and glioblastoma: Importantly, we found that C5aR1 is highly expressed in tMSLCs, while its expression level was substantially lower in GBM cells, providing an explanation for why HAS2 is not induced by treatment with rh-C5a in GBM cells (Figure 3I).